Long-term results from INT-HER study: Retrospective evaluation of adjuvant trastuzumab in unselected HER2-positive breast cancer patients—Single institution experience.
Angela Moliterni
No relevant relationships to disclose
Gabriella Mariani
No relevant relationships to disclose
Giulia Carlo Stella
No relevant relationships to disclose
Luigi Mariani
No relevant relationships to disclose
Giulia Valeria Bianchi
No relevant relationships to disclose
Giuseppe Capri
No relevant relationships to disclose
Sara Cresta
No relevant relationships to disclose
Paola Mariani
No relevant relationships to disclose
Silvia Damian
No relevant relationships to disclose
Elena De Benedictis
No relevant relationships to disclose
Francesco Gelsomino
No relevant relationships to disclose
Elisa Zanardi
No relevant relationships to disclose
Matteo Duca
No relevant relationships to disclose
Lorenzo Sica
No relevant relationships to disclose
Anna Tessari
No relevant relationships to disclose
Filippo G. De Braud
Consultant or Advisory Role - Novartis (U); Philogen (U); Pierre Fabre Medicament (U); Roche (U); SERVIER (U)